This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Karo Pharma Balance Sheet Health
Financial Health criteria checks 1/6
Key information
104.8%
Debt to equity ratio
kr8.65b
Debt
| Interest coverage ratio | 0.2x |
| Cash | kr353.10m |
| Equity | kr8.26b |
| Total liabilities | kr10.24b |
| Total assets | kr18.49b |
Recent financial health updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14
Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Recent updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality
Feb 24Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?
Feb 22Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?
Feb 01
Financial Position Analysis
Short Term Liabilities: KARO's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Long Term Liabilities: KARO's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Debt to Equity History and Analysis
Debt Level: KARO's net debt to equity ratio (100.5%) is considered high.
Reducing Debt: KARO's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Debt Coverage: KARO's debt is not well covered by operating cash flow (5.9%).
Interest Coverage: KARO's interest payments on its debt are not well covered by EBIT (0.2x coverage).